Health

Despite the preferences of some, Moderna announced that after years of work, mFLUSIVA (mRNA-1010) has been approved for use in adults aged 50 to 64, with an accelerated approval for adults 65 and up as they wait for the results of a follow-up study.

As reported earlier by the Washington Post, the CDC has updated its notice about parasite infections linked to now-recalled lettuce from Taylor Farms. The CDC noted it’s investigating other cases nationally “that are unrelated to this outbreak,” and today the FDA disclosed a new cyclospora outbreak with 72 cases, in addition to its three existing active cyclospora outbreak investigations.

An advisory panel, stacked with RFK Jr.’s pro-peptide appointees, has voted to add BPC-157 and KPV to the bulk compounding list. This is despite FDA staff clinicians stating that there’s no convincing evidence. Central to the argument is whether allowing compounding will curtail the gray market or expose the public to unnecessary risk. Internally screaming.

By leveraging data sourced from a Galaxy smartphone, smartwatch, or smart ring, the new Samsung Health Assistant can help users better understand their health while also providing guidance and recommendations on how they can improve it through “meaningful changes in their lifestyle.” The assistant is now in beta for eligible users in the US.

Citing two unnamed sources familiar with the investigation, the Washington Post reported Thursday night that, based on reports from many of the people who fell ill, investigators “have identified shredded iceberg lettuce supplied to Taco Bell restaurants by Taylor Farms as a potential source of contamination.”

If you are, Withings’ BodyScan 2 is available to buy starting today. Why is the scale $600? Well, it measures 60 biomarkers, and it’s positioned as a “longevity station.”

The “Whoop, but for the Apple Watch” app now integrates with Google Health. If you didn’t think the Fitbit Air was a Whoop competitor before, it sure might be now. Especially considering Whoop is suing them.

Sure, you could buy a smart scale for a body composition breakdown, but why bother?

Where else can you find cutting edge gadget coverage and excellent sunscreen recommendations?

During the VivaTech 2026 conference in Paris, Samsung announced a new feature for its mobile devices created through a collaboration with the pet health management platform, Lifet. You’ll be able to snap a photo of your dog or cat which will be analyzed by AI to alert you to conditions like periodontal disease and obesity.

The controversial birth control app is rolling out “Sleep Insights,” allowing users to view key metrics — including sleep duration, efficiency, and timing — alongside their daily fertility status. It requires either an Oura Ring or Natural Cycles Band wearable, and over time, can show how hormonal changes and menstrual phases can impact sleep patterns.

Oura says New Yorkers’ hearts were palpitating on Wednesday night during Game 4. Turns out, baseline heart rates increased by 3.7 beats on average at the final buzzer. Heart rates were also elevated for the entirety of the game, and nobody seemed to get a peaceful night of sleep. Guessing we’re in for more of the same on Saturday.

A sun exposure-tracking pendant, in case they’re running low on tech-induced anxiety.

It’s a similar idea as L’Oréal’s My Skin Track UV sensor, but the $299 (discounted to $199 at launch) Gem smart jewelry wearable from The90 is a more stylish alternative. Its sensors measure UVA and UVB exposure throughout the day and based on your skin profile it will tell you how much sun is safe to get and when to reapply sunscreen through an app.

Peloton has acquired Skōp, a Pilates-focused startup that builds real-time form-tracking technology. That suggests there might be new Peloton hardware on the horizon, as the company tries to recover from its post-covid slump. In a statement, Peloton CEO Peter Stern said:

First off, it announced today that it plans to acquire Nutrisense — a CGM startup that targets nondiabetics. Stelo, its over-the-counter CGM, is also getting an FDA-cleared redesign that includes “pattern recognition, proactive AI coaching, and personalized weekly and daily summaries.” Hopefully, these moves help ease the data fatigue I experienced in my yearlong experiment with CGMs as a nondiabetic.

The BodyFit, available starting today, is a more affordable alternative to Withings’s $600 “longevity station” BodyScan 2 or the original BodyScan, which got a tariff price hike to $499.95 last year. Withings claims the BodyFit can deliver a “DEXA-level” “full-spectrum, 6-zone body composition scan in just 10 seconds.”